We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VIZO-PF BIMATOTIM 0.3/5 (AFT Pharmaceuticals Pty Ltd)
Product name
VIZO-PF BIMATOTIM 0.3/5
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
151 (255 working days)
Active ingredients
bimatoprost; timolol maleate
Registration type
New generic medicine
Indication
VIZO-PF BIMATOTIM 0.3/5 (eye drops) is indicated for the reduction of intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine